Nutriband Inc - Asset Resilience Ratio

Latest as of January 2019: 0.00%

Nutriband Inc (NTRB) has an Asset Resilience Ratio of 0.00% as of January 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Nutriband Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$2.81 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2019)

This chart shows how Nutriband Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Nutriband Inc (NTRB) total assets.

Liquid Assets Composition Over Time

This chart breaks down Nutriband Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Nutriband Inc carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Nutriband Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Nutriband Inc Industry Peers by Asset Resilience Ratio

Compare Nutriband Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ALK-Abelló A/S
CO:ALK-B
Biotechnology 0.98%
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Biotechnology 6.89%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
BB Biotech AG
SW:BION
Biotechnology 92.97%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Nanobiotix
NASDAQ:NBTX
Biotechnology 4.71%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
Biotechnology 10.55%

Annual Asset Resilience Ratio for Nutriband Inc (2019–2019)

The table below shows the annual Asset Resilience Ratio data for Nutriband Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-01-31 0.00% $0.00 $2.81 Million --
pp = percentage points

About Nutriband Inc

NASDAQ:NTRB USA Biotechnology
Market Cap
$92.99 Million
Market Cap Rank
#20664 Global
#4680 in USA
Share Price
$7.65
Change (1 day)
+8.66%
52-Week Range
$2.81 - $8.50
All Time High
$43.54
About

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company… Read more